C. Ericson
- Surgery top 10%
- Endocrinology, Diabetes and Metabolism top 10%
- Cancer Research
- Cardiology and Cardiovascular Medicine
- Immunology
- Co-authors
- G. DahlénK. BergL LundkvistCurt D. FurbergKurt SvärdsuddC.D. FurbergUlf dé FairéT Lundman
- Topics
- Lipoproteins and Cardiovascular Health (8 papers)Cancer, Lipids, and Metabolism (3 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers)
- Partner nations
- SwedenNorwayUnited States
In The Last Decade
C. Ericson
18 papers receiving 384 citations
Peers
Comparison fields: 5 of 58
- Surgery 303
- Endocrinology, Diabetes and Metabolism 135
- Cancer Research 131
- Cardiology and Cardiovascular Medicine 102
- Immunology 52
Countries citing papers authored by C. Ericson
This map shows the geographic impact of C. Ericson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ericson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ericson more than expected).
Fields of papers citing papers by C. Ericson
This network shows the impact of papers produced by C. Ericson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ericson. The network helps show where C. Ericson may publish in the future.
Co-authorship network of co-authors of C. Ericson
This figure shows the co-authorship network connecting the top 25 collaborators of C. Ericson. A scholar is included among the top collaborators of C. Ericson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ericson. C. Ericson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 26 | |
| 3 | 16 | |
| 4 | 25 | |
| 5 | The effect of Gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC). | 23 |
| 6 | Effect of gemfibrozil on serum lipid levels. | 13 |
| 7 | 44 | |
| 8 | 24 | |
| 9 | 15 | |
| 10 | 93 | |
| 11 | 3 | |
| 12 | 23 | |
| 13 | Studies on an extra pre-beta lipoprotein fraction. | 63 |
| 14 | 13 | |
| 15 | 4 | |
| 16 | 4 | |
| 17 | 22 | |
| 18 | 1 |
About C. Ericson
C. Ericson is a scholar working on Immunology and Allergy, Endocrinology, Diabetes and Metabolism and Surgery, having authored 18 papers that have together received 413 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (8 papers), Cancer, Lipids, and Metabolism (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Cancer Research (131 citations), Endocrinology, Diabetes and Metabolism (135 citations) and Surgery (303 citations). C. Ericson has collaborated with scholars based in Sweden, Norway and United States. Frequent co-authors include G. Dahlén, K. Berg, K. Berg, L Lundkvist, Curt D. Furberg, Kurt Svärdsudd, C.D. Furberg, Ulf dé Fairé, T Lundman and M. H. Frick. Their work appears in journals such as International Journal of Epidemiology, Pharmacological Research and Clinical Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.